The microbiota and inflammatory bowel disease: insights from animal models.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Anaerobe

• Publication date

  2013-12-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.anaerobe.2013.04.006PMID 23603043PMCID PMC3766478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microbiota, Disease, and Back to Health: A Metastable Journey

  2012cited by this paper
• Materials for : Host-microbe interactions shape genetic risk for inflammatory bowel disease

  2012cited by this paper
• Acute Gastrointestinal Infection Induces Long-Lived Microbiota-Specific T Cell Responses

  2012influential reference
• Animal models of inflammatory bowel disease.

  2012cited by this paper
• Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species

  2011cited by this paper
• Genetics and pathogenesis of inflammatory bowel disease

  2011cited by this paper
• Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

  2011cited by this paper
• Induction of IDO-1 by Immunostimulatory DNA Limits Severity of Experimental Colitis

  2010cited by this paper
• Homeostasis and inflammation in the intestine.

  2010cited by this paper
• Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer

  2010cited by this paper
• Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction

  2010cited by this paper
• Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis.

  2010influential reference
• Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota

  2010cited by this paper
• Induction of intestinal Th17 cells by segmented filamentous bacteria.

  2009influential reference
• Low counts of Faecalibacterium prausnitzii in colitis microbiota

  2009cited by this paper
• RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.

  2009cited by this paper
• Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine.

  2008cited by this paper
• An Antibiotic-Responsive Mouse Model of Fulminant Ulcerative Colitis

  2008cited by this paper
• Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study

  2008cited by this paper
• Inflammatory bowel disease, past, present and future: lessons from animal models

  2008cited by this paper
• A microbial symbiosis factor prevents intestinal inflammatory disease

  2008cited by this paper
• Unravelling the pathogenesis of inflammatory bowel disease

  2007cited by this paper
• Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

  2007cited by this paper
• Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system.

  2007cited by this paper
• The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

  2006cited by this paper
• Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice.

  2006cited by this paper
• Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.

  2005cited by this paper
• Bacterial flagellin is a dominant antigen in Crohn disease.

  2004cited by this paper
• CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice.

  2003cited by this paper
• Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2

  2003cited by this paper
• Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice.

  2000cited by this paper
• Segmented Filamentous Bacteria Are Potent Stimuli of a Physiologically Normal State of the Murine Gut Mucosal Immune System

  1999cited by this paper
• Differential Roles of Segmented Filamentous Bacteria and Clostridia in Development of the Intestinal Immune System

  1999cited by this paper
• Animal models of mucosal inflammation and their relation to human inflammatory bowel disease.

  1999cited by this paper
• Spontaneous Inflammatory Bowel Disease in Multiple Mutant Mouse Lines: Association with Colonization by Helicobacter hepaticus

  1998cited by this paper
• Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus

  1997cited by this paper
• Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora

  1997cited by this paper
• Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

  1996cited by this paper
• Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus.

  1996cited by this paper
• Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice

  1993cited by this paper
• Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

  1993cited by this paper
• Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice.

  1993cited by this paper
• Habitat, Succession, Attachment, and Morphology of Segmented, Filamentous Microbes Indigenous to the Murine Gastrointestinal Tract

  1974cited by this paper
• lnterleukin-10-Deficient Mice Develop Chronic Enterocolitis

  year unknowncited by this paper
• The Orphan Nuclear Receptor ROR g t Directs the Differentiation Program of Proinflammatory IL-17 + T Helper Cells

  year unknowncited by this paper

• Polysaccharides derived from Aconitum carmichaelii Debx attenuate intestinal mucositis through anti-inflammatory activity and regulation of intestinal microbiota metabolism in mice

  2025cites this paper
• Integrating Biological Domain Knowledge with Machine Learning for Identifying Colorectal-Cancer-Associated Microbial Enzymes in Metagenomic Data

  2025cites this paper
• Gut microbiota-derived 5-hydroxyindoleacetic acid from pumpkin polysaccharides supplementation alleviates colitis via MAPKs-PPARγ/NF-κB inhibition.

  2024cites this paper
• Appendix: “an appendage to a twelve-meter gut or a storehouse for microbiota”?

  2024cites this paper
• Reevaluating Biota Alteration: Reframing Environmental Influences on Chronic Immune Disorders and Exploring Novel Therapeutic Opportunities

  2024cites this paper
• Appendiceal periappendicitis and ulcerative colitis: Relationship and research advances

  2024cites this paper
• Diagnosis of Crohn’s disease and ulcerative colitis using the microbiome

  2023cites this paper
• A nexus of dietary restriction and gut microbiota: Recent insights into metabolic health

  2023cites this paper
• Isolation and Detection of UreC and UreR of Proteus mirabilis in Gastrointestinal Samples from Patients with Crohn's Disease in Iraq

  2023cites this paper
• Dietary flavonoids-microbiota crosstalk in intestinal inflammation and carcinogenesis.

  2023cites this paper
• Appendix and Ulcerative Colitis: a Key to Explaining the Pathogenesis and Directing Novel Therapies?

  2022cites this paper
• Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota

  2022cites this paper
• Bacteroides vulgatus attenuates experimental mice colitis through modulating gut microbiota and immune responses

  2022cites this paper
• Polysaccharide from Scutellaria barbata D. Don attenuates inflammatory response and microbial dysbiosis in ulcerative colitis mice.

  2022cites this paper
• Establishment and evaluation of a specific antibiotic-induced inflammatory bowel disease model in rats

  2022cites this paper
• Alterations in Gut Microbiota and Upregulations of VPAC2 and Intestinal Tight Junctions Correlate with Anti-Inflammatory Effects of Electroacupuncture in Colitis Mice with Sleep Fragmentation

  2022cites this paper
• Microbiota in health and diseases

  2022cites this paper
• Anti-inflammatory effects of purple sweet potato anthocyanin extract in DSS-induced colitis: modulation of commensal bacteria and attenuated bacterial intestinal infection.

  2021cites this paper
• Inhibition of PD-1 Protects against TNBS-Induced Colitis via Alteration of Enteric Microbiota

  2021cites this paper
• Dietary restrictions modulate the gut microbiota: Implications for health and disease.

  2021cites this paper
• Evaluation of E. coli Nissle1917 derived metabolites in modulating key mediator genes of the TLR signaling pathway

  2021cites this paper
• Microbiome in Human Gastrointestinal Cancers

  2021cites this paper
• The microbiome—the revealing of a long time unbeknownst factor for outcome in murine models of graft-versus-host disease

  2021cites this paper
• The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease

  2021cites this paper
• The Gastrointestinal Tract

  2021cites this paper
• Microbiome-Mediated Immune Signaling in Inflammatory Bowel Disease and Colorectal Cancer: Support From Meta-omics Data

  2021influential citation
• Zeolite‐containing mixture alleviates microbial dysbiosis in dextran sodium sulfate‐induced colitis in mice

  2020cites this paper
• Establishment and evaluation of specific antibiotic-induced Inflammatory bowel disease (IBD) model in rats

  2020cites this paper
• Establishment and evaluation of specific antibiotic-induced Inflammatory bowel disease (IBD) model in rats CURRENT

  2020cites this paper
• The association among enterobacterial flora, dietary factors, and prognosis in patients with ulcerative colitis.

  2020cites this paper
• Fecal transplantation for ulcerative colitis: current evidence and future applications

  2020cites this paper
• Role of the microbiota in ileitis of a mouse model of inflammatory bowel disease—Glutathione peroxide isoenzymes 1 and 2‐double knockout mice on a C57BL background

  2020influential citation
• Short-Term Cohousing of Sick with Healthy or Treated Mice Alleviates the Inflammatory Response and Liver Damage

  2020cites this paper
• Compound polysaccharides ameliorate experimental colitis by modulating gut microbiota composition and function

  2019cites this paper
• Matrine Mediates Inflammatory Response via Gut Microbiota in TNBS-Induced Murine Colitis

  2019cites this paper
• Researching New Therapeutic Approaches for Abdominal Visceral Pain Treatment: Preclinical Effects of an Assembled System of Molecules of Vegetal Origin

  2019cites this paper
• Long noncoding RNA BFAL1 mediates enterotoxigenic Bacteroides fragilis-related carcinogenesis in colorectal cancer via the RHEB/mTOR pathway

  2019cites this paper
• Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition

  2019cites this paper
• Weight loss is a sufficient and economical single outcome measure of murine dextran sulfate sodium colitis

  2019cites this paper
• Intestinal microbiota predicts lung cancer patients at risk of immune-related diarrhea.

  2019cites this paper
• Effects of microbiota modulations on host intestinal epithelial defense responses

  2019cites this paper
• Synthetic Biology and the Gut Microbiome

  2018cites this paper
• Immune Relevant and Immune Deficient Mice: Options and Opportunities in Translational Research

  2018cites this paper
• Environmental factors regulate Paneth cell phenotype and host susceptibility to intestinal inflammation in Irgm1-deficient mice

  2018cites this paper
• Genetic variation and expression levels of tight junction genes identifies association between MAGI3 and inflammatory bowel disease

  2017cites this paper
• Gnotobiotics and Inflammatory Bowel Disease

  2017cites this paper
• Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer

  2017cites this paper
• P. pentosaceus Administration Attenuates the Severity of Dextran Sulfate Sodium-Induced Colitis and Improve the Intestinal Permeability

  2017cites this paper
• Efectos de la microbiota intestinal y sistema inmune en el trasplante

  2017cites this paper
• Cell-Surface and Nuclear Receptors in the Colon as Targets for Bacterial Metabolites and Its Relevance to Colon Health

  2017cites this paper
• Modulation of Gut Microbiome Composition and Function in Experimental Colitis Treated with Sulfasalazine

  2017cites this paper
• Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis

  2017cites this paper
• Fecal microbiome in dogs with inflammatory bowel disease and intestinal lymphoma

  2017cites this paper
• Análisis del riesgo de cáncer colorrectal en pacientes con múltiples pólipos serrados y estudio de marcadores moleculares con implicaciones en su diagnóstico y prevención

  2017cites this paper
• Bacterial Overgrowth and Intestinal Microbiome

  2016cites this paper
• Antibiotic Treatment Induces Long-lasting Changes in the Fecal Microbiota that Protect Against Colitis

  2016cites this paper
• Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells

  2016cites this paper
• Tumor necrosis factor and lymphotoxin in regulation of intestinal inflammation

  2016cites this paper
• Translocation of Klebsiella from Enteral Diets: Study through Mouse Model System and Molecular Technique

  2016cites this paper
• Gut Microbiota: A Possible Role in the Pathogenesis of Multiple Sclerosis

  2016cites this paper
• In vitro modulation of tumor necrosis factor α production in THP-1 cells by lactic acid bacteria isolated from healthy human infants.

  2015cites this paper
• Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage

  2015cites this paper
• Rifaximin: An Antibiotic with Important Biologic Effects.

  2015cites this paper
• New insights into gastrointestinal anthrax infection.

  2015cites this paper
• Anti-inflammatory properties of fermented soy milk with Lactococcus lactis subsp. lactis S-SU2 in murine macrophage RAW264.7 cells and DSS-induced IBD model mice.

  2015cites this paper
• Animal Farm: Considerations in Animal Gastrointestinal Physiology and Relevance to Drug Delivery in Humans.

  2015cites this paper
• Depletion of enteroantigen-activated CD4⁺ T cells: effects on proliferation and pathogenicity.

  2015cites this paper
• Administration of Probiotics Normalizes Deficits in the Microbiota‐Gut‐Brain Axis Induced by DSS‐Colitis

  2015cites this paper
• Chapter 26 – Gnotobiotics

  2015cites this paper
• How informative is the mouse for human gut microbiota research?

  2015influential citation
• UNIVERISTY OF CALIFORNIA, SAN DIEGO Administration of Probiotics Normalizes Deficits in the Microbiota-Gut-Brain Axis Induced by DSS-Colitis A thesis submitted in partial satisfaction of the requirements for the degree of Master of Science in Biology by

  2015cites this paper
• The Structure and Function of the Starch Utilization System in Bacteroides thetaiotaomicron.

  2014cites this paper
• A study on three aspects of Inflammatory Bowel Disease's Triad of Susceptibility: Hormones, Helminths and T regulatory cells, in the Helicobacter hepaticus mouse model for IBD

  2014cites this paper
• Inhibitory effects of Leuconostoc mesenteroides 1RM3 isolated from narezushi on lipopolysaccharide-induced inflammation in RAW264.7 mouse macrophage cells and dextran sodium sulphate-induced inflammatory bowel disease in mice

  2014cites this paper
• E. coli adhérentes et invasives et pathogénèse de la maladie de Crohn : rôle du facteur hypoxique HIF-1

  2013cites this paper
• EXAMINATION OF STATIONARY-PHASE GENE EXPRESSION IN CONTEXT OF REAL-WORLD APPLICATIONS OF SYNTHETIC MICROBES

  year unknowncites this paper